Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells

A Functionally Significant Cross-talk between Androgen Receptor and ErbB2 Pathways in Estrogen Receptor Negative Breast Cancer

(2015) Ali Naderi et al.   NEOPLASIA

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy

(2010) Luciana Schultz et al.   CANCER

Expression of semenogelins I and II and its prognostic significance in human prostate cancer

(2010) Anastasia M. Canacci et al.   PROSTATE

Androgen Receptor Is a Potential Therapeutic Target for Bladder Cancer

(2010) Ji-Tao Wu et al.   UROLOGY

Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers

(2010) Donata Micello et al.   VIRCHOWS ARCHIV

Expression of androgen receptors in primary breast cancer

(2009) S. Park et al.   ANNALS OF ONCOLOGY

Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth

(2009) A M Traish et al.   BRITISH JOURNAL OF CANCER

Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer

(2009) Margaret A. Knowles et al.   CANCER AND METASTASIS REVIEWS

Androgen Receptor Controls EGFR and ERBB2 Gene Expression at Different Levels in Prostate Cancer Cell Lines

(2009) J.-C. Pignon et al.   CANCER RESEARCH

Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response

(2009) Ramaswamy Bhuvaneswari et al.   Molecular Cancer

Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations

(2009) Maria Karlou et al.   PATHOLOGY

Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: A comparative analysis of clinicopathological features and survival outcomes according to receptor expression

(2009) Can Tuygun et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder

(2008) Stephen A Boorjian et al.   ENDOCRINE-RELATED CANCER

Sensitivity of Normal, Paramalignant, and Malignant Human Urothelial Cells to Inhibitors of the Epidermal Growth Factor Receptor Signaling Pathway

(2008) N. J. MacLaine et al.   MOLECULAR CANCER RESEARCH

Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1

(2008) Aimee M Johnson et al.   BMC Urology